Search the Newsreel

Regency Centers’ Higher Payouts and Raised Guidance Might Change The Case For Investing In REG

Regency Centers recently declared higher quarterly cash dividends and raised its full-year Nareit FFO and same-property NOI guidance, signaling confidence in its operating performance and a continued focus on distributing cash to shareholders. This move reinforces the REIT's income-focused thesis, emphasizing the durability of …

Lakhbir Lamba Bought 22% More Shares In Regional Management

Lakhbir Lamba, President of Regional Management Corp. (NYSE:RM), recently increased his stake by 22%, purchasing US$316k worth of shares at US$31.65 each. While this is a strong insider buy, overall insider selling exceeded buying over the last year, though the sales were at a …

Regency Centers (REG) Q2 2026 Earnings Call Transcript

Walleye Capital LLC Invests $2.44 Million in REGENXBIO Inc. $RGNX

Walleye Capital LLC has invested $2.44 million in REGENXBIO Inc. by acquiring 203,726 shares during the second quarter, making them one of many institutional investors in the company. REGENXBIO exceeded analyst expectations with its recent earnings report, posting $0.43 EPS and $108.02 million in …

7,506 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Summit Global Investments

Summit Global Investments acquired 7,506 shares of Regeneron Pharmaceuticals (NASDAQ:REGN) valued at $4.68 million during the second quarter. Regeneron reported strong quarterly results, beating analyst estimates with $14.29 EPS and $4.29 billion in revenue, representing a 16.7% year-over-year increase. Despite a "Moderate Buy" consensus …

Regions Financial Corporation $RF Shares Bought by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA increased its stake in Regions Financial Corporation by 1% in the second quarter, now owning 7.19 million shares valued at $217.6 million. Institutional investors collectively hold 79.39% of the company. Regions Financial exceeded earnings expectations, reporting $0.68 EPS against …

6,820 Shares in Regal Rexnord Corporation $RRX Bought by Dockside LLC

Dockside LLC recently acquired 6,820 shares of Regal Rexnord Corporation (NYSE:RRX) for approximately $1.62 million in the second quarter. This move is part of broader institutional interest, as institutional investors own 99.72% of the company's stock. Analysts generally maintain a "Moderate Buy" rating for …

How Securities Lawsuits Over Trial Disclosures Will Impact Regeneron Pharmaceuticals’ (REGN) Pipeline-Driven Investment Story

Regeneron Pharmaceuticals is facing securities class action lawsuits concerning alleged misleading statements about its Phase III Fianlimab-Libtayo trial. These lawsuits, focusing on disclosure practices regarding trial delays and failure, could influence investor perception of Regeneron's pipeline-driven strategy, especially as the company advances new programs …

Wall Street Zen Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Strong-Buy

Wall Street Zen has upgraded Regeneron Pharmaceuticals (NASDAQ:REGN) from a "buy" to a "strong-buy" rating. This upgrade follows Regeneron's strong quarterly earnings, where it surpassed analyst expectations for both EPS and revenue. Despite positive news regarding pipeline expansion and collaborations, the company faces risks …

EREGLI DEMIR CELIK Hisse Senedi Canlı Grafik

Is Biohaven (BHVN)’s Latest Regeneron Pharmaceuticals (REGN) Deal a Major Catalyst for its Pipeline?

Two prominent biopharmaceutical names, Biohaven Ltd. (NYSE:BHVN) and Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), are deepening their relationship across oncology. On July 20, Biohaven announced a clinical supply agreement with Regeneron to evaluate the combination of BHV-1530 and Regeneron's cemiplimab (Libtayo) in patients with solid tumors. …

Bernstein Lifts Regeneron Price Target to $756, Stays on Sidelines

Bernstein has raised its price target for Regeneron Pharmaceuticals to $756 from $753, while maintaining a Market Perform rating, indicating a slightly more positive near-term outlook but not a fundamental shift in its investment thesis. This new target remains below the Wall Street consensus …

Regal Rexnord Orders Surge, Yet Margin Outlook Drops: What Analysts Asked

Regal Rexnord reported strong Q2 2026 order growth, especially in Automation and Motion Control, but simultaneously lowered its full-year adjusted EBITDA margin and free cash flow guidance due to slower productivity savings, lagging price realization against inflation, and unfavorable segment mix. New CEO Aamir …

Regaal Resources net profit rises 47% YoY to ₹133.3 million in Q1FY27

Regaal Resources Q1 Results: Net profit rises 47% YoY to ₹133.3 million

Regaal Resources standalone net profit rises 46.97% in the June 2026 quarter

Iris Regtech holds 26th AGM, approves director reappointments

REGENXBIO (NASDAQ:RGNX) Rating Increased to Hold at Zacks Research

Zacks Research has upgraded REGENXBIO (NASDAQ:RGNX) from a "strong sell" to a "hold" rating. This upgrade comes as the biotechnology company exceeded revenue and EPS estimates in its latest quarterly report, though it remains unprofitable. Institutional investors hold a significant portion of the company's …

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating

Bernstein has increased its price target for Regeneron Pharmaceuticals (REGN) to $756 from $753, while maintaining a "Market Perform" rating on the stock. This adjustment reflects a modest change in the analyst's valuation, indicating a continued neutral stance on the company's stock performance. The …

Saregama India Ltd. Share Price Today - Saregama India Ltd. Stock Price Live NSE/BSE

Wedge Capital Management L L P NC Decreases Stock Holdings in Regions Financial Corporation $RF

Wedge Capital Management L L P NC significantly reduced its stake in Regions Financial Corporation (NYSE:RF) by 90.8% in the second quarter, selling 1.15 million shares and retaining 115,623 shares valued at $3.49 million. Regions Financial reported strong quarterly earnings of $0.68 EPS, surpassing …

Assenagon Asset Management S.A. Has $2.03 Million Position in REGENXBIO Inc. $RGNX

Assenagon Asset Management S.A. significantly reduced its stake in REGENXBIO Inc. by 82.7% in the second quarter, now holding 169,279 shares valued at $2.03 million. Despite this, institutional investors still own a substantial 88.08% of the company. REGENXBIO recently surpassed analyst estimates for quarterly …

Alnylam Pharmaceuticals (ALNY) Cuts Guidance As Undervalued Narrative Faces A Tougher Test

Alnylam Pharmaceuticals (ALNY) recently cut its full-year 2026 TTR product sales guidance by $200 million and is under a securities law investigation, leading to significant share price pressure. Despite a "most popular narrative" suggesting the stock is 47.8% undervalued with a fair value of …

Regency Ceramics Ltd. Share Price Fall and Stock Analysis

Regency Ceramics Publishes June-Quarter Unaudited Results in Leading Dailies

Regency Ceramics Q1 Results: Revenue up 173% YoY, net loss narrows

Regency Ceramics reports standalone net loss of Rs 2.57 crore in the June 2026 quarter

5 Must-Read Analyst Questions From Regal Rexnord’s Q2 Earnings Call

5 Must-Read Analyst Questions From Regal Rexnord's Q2 Earnings Call Regal Rexnord's second quarter saw its sales growth fall short of Wall Street's expectations, driving a significant negative market reaction. Management attributed the shortfall to persistent weakness in residential HVAC and pool markets, as …

Regal Partners Global Investments posts strong July amid financials and gold sector moves

RRX|Regal Rexnord Corp|Price:172.306|Chg%:-0.594

This article provides a detailed financial overview of Regal Rexnord Corp (RRX), including its stock price, key figures, and recent performance. It highlights the company's stock score, analyst ratings, and technical analysis, showing a "Buy" consensus with a target price significantly above the current …

Regional Management (NYSE:RM) CEO Acquires $111,160.00 in Stock

Regional Management CEO Lakhbir Lamba recently purchased 3,500 shares of the company's stock for $111,160, increasing his direct stake by 6.7%. The company reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and declared a quarterly dividend. Despite the CEO's purchase …

Regional Management (NYSE:RM) CEO Purchases 6,500 Shares

Regional Management (NYSE:RM) CEO Lakhbir Lamba recently purchased 6,500 shares of the company's stock for over $205,000, increasing his direct ownership by 14.21%. The company reported strong quarterly earnings, beating analyst estimates for both EPS and revenue, and declared a quarterly dividend of $0.30 …

Regional Management Corp. (RM) CEO purchases 10,000 shares in open market trades

Regional Management Corp. CEO Lakhbir S. Lamba purchased 10,000 shares of the company's common stock in open market transactions on August 11-12, 2026. The purchases were executed at weighted average prices in the low $30s per share. This insider buying demonstrates a positive sentiment, …